Raymond James & Associates’s Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest JHY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-113,396
| Closed | -$1.07M | – | 3954 |
|
|
2020
Q3 | $1.07M | Sell |
113,396
-16,688
| -13% | -$158K | ﹤0.01% | 2136 |
|
|
2020
Q2 | $1.21M | Buy |
130,084
+67,677
| +108% | +$621K | ﹤0.01% | 2029 |
|
|
2020
Q1 | $550K | Buy |
62,407
+11,052
| +22% | +$105K | ﹤0.01% | 2360 |
|
|
2019
Q4 | $502K | Buy |
51,355
+11,044
| +27% | +$109K | ﹤0.01% | 2740 |
|
|
2019
Q3 | $400K | Sell |
40,311
-5,813
| -13% | -$58.1K | ﹤0.01% | 2815 |
|
|
2019
Q2 | $455K | Buy |
46,124
+3,266
| +8% | +$32.5K | ﹤0.01% | 2751 |
|
|
2019
Q1 | $426K | Buy |
42,858
+7,878
| +23% | +$78.6K | ﹤0.01% | 2770 |
|
|
2018
Q4 | $347K | Buy |
34,980
+24,908
| +247% | +$244K | ﹤0.01% | 2780 |
|
|
2018
Q3 | $97K | Hold |
10,072
| – | – | ﹤0.01% | 3443 |
|
|
2018
Q2 | $101K | Hold |
10,072
| – | – | ﹤0.01% | 3398 |
|
|
2018
Q1 | $99K | Sell |
10,072
-1,124
| -10% | -$11.1K | ﹤0.01% | 3269 |
|
|
2017
Q4 | $111K | Sell |
11,196
-19,270
| -63% | -$193K | ﹤0.01% | 3193 |
|
|
2017
Q3 | $308K | Sell |
30,466
-55,862
| -65% | -$564K | ﹤0.01% | 2779 |
|
|
2017
Q2 | $871K | Buy |
86,328
+123
| +0.1% | +$1.25K | ﹤0.01% | 2115 |
|
|
2017
Q1 | $874K | Buy |
86,205
+7,615
| +10% | +$77.7K | ﹤0.01% | 2059 |
|
|
2016
Q4 | $802K | Buy |
78,590
+3,191
| +4% | +$32.6K | ﹤0.01% | 2059 |
|
|
2016
Q3 | $795K | Buy |
+75,399
| New | +$789K | ﹤0.01% | 2013 |
|
Raymond James & Associates's JHY Position: Q4 2020 in Review
Raymond James & Associates sold out of Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest (JHY) in Q4 2020, closing a stake of 113,396 shares — an estimated $1.07M sold.
Raymond James & Associates first reported a position in JHY in Q3 2016 and held it in 17 quarters. The position peaked at $1.21M in Q2 2020. 0 funds tracked by Wall St. Rank hold JHY as of Q4 2020.
- Raymond James & Associates reported no remaining Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest position as of Q4 2020 after selling out during the quarter.
- Raymond James & Associates sold 113,396 Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest shares in Q4 2020, an estimated $1.07M.
- Raymond James & Associates first reported a position in Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest in Q3 2016 and held it in 17 quarters.
- Raymond James & Associates's Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest position peaked at $1.21M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest as of Q4 2020.
Based on Raymond James & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.